Intravenous tissue plasminogen activator for patients with minor ischemic stroke.

  title={Intravenous tissue plasminogen activator for patients with minor ischemic stroke.},
  author={Branko N. Huisa and R. Ramalakshmi Raman and Will Neil and Karin B Ernstrom and Thomas Martin Hemmen},
  journal={Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association},
  volume={21 8},
BACKGROUND Patients with minor ischemic stroke (MIS) are frequently excluded from thrombolytic therapy. Denial of therapy to these patients, however, remains controversial. We compared outcomes in patients with MIS who received intravenous (IV) tissue plasminogen activator (t-PA) with those who were not treated. METHODS We selected adult patients with stroke onset within 3 hours from a prospectively collected stroke registry. MIS was defined as an admission National Institutes of Health… CONTINUE READING


Publications citing this paper.
Showing 1-9 of 9 extracted citations

Safety and Outcome of Thrombolysis in Mild Stroke: A Meta-Analysis

Medical science monitor : international medical journal of experimental and clinical research • 2014
View 15 Excerpts
Highly Influenced

Should minor stroke patients be thrombolyzed? A focused review and future directions.

International journal of stroke : official journal of the International Stroke Society • 2015

Treatment of cerebral infarction at the stroke unit in Bodø 2011-12.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke • 2013
View 1 Excerpt


Publications referenced by this paper.
Showing 1-10 of 19 references

What is a minor stroke? Stroke 2010;41:661-666

U Fischer, A Baumgartner, M Arnold

Similar Papers

Loading similar papers…